Gabelli & Co Investment Advisers’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
EC
CCM
EAM
CCM
GIM
Gabelli & Co Investment Advisers's EVH Position: Q4 2024 in Review
Gabelli & Co Investment Advisers sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 10,250 shares — an estimated $290K sold.
Gabelli & Co Investment Advisers first reported a position in EVH in Q3 2017 and held it in 21 quarters. The position peaked at $338K in Q2 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.
- Gabelli & Co Investment Advisers reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 10,250 Evolent Health shares in Q4 2024, an estimated $290K.
- Gabelli & Co Investment Advisers first reported a position in Evolent Health in Q3 2017 and held it in 21 quarters.
- Gabelli & Co Investment Advisers's Evolent Health position peaked at $338K in Q2 2022.
- 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.
Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2024, filed 13 Feb 2025.